Using Nogo-B deficient mice, she demonstrated that Nogo-B attenuates liver fibrosis by disturbing the Tgf-β/Smad2 pathway and inducing apoptosis of activated stellate cells. The gene discussed is TGFB1; the disease is Hepatic fibrosis.